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whereas the severity ofspontaneous chronic
nephropathy in treated male rats relative to
controls increased from 52 and 104 weeks.
As a result of the current discussion in
the literature (3), the kidney specimens were
reanalyzed for the hallmarks of x2u-globulin
nephropathy sequelae, namely the presence
of granular casts and linear mineralization
(8). These changes were not observed in
male rats receiving 250, 1,000, or 2,000
mg/kg ofgabapentin for 2 years. In terms of
proliferative effects, therewere 3 foci ofatyp-
ical hyperplasia of renal tubules: 2/50 were
found in male rats at 1,000 mg/kg and 1/50
male rats at 2,000 mg/kg of gabapentin.
These kidney examinations in the 2-year
study included four sections (two from each
kidney) from every animal in the group
(50/sex/group), amounting to 1,600 kidney
sections in the 2-year rat study. This stan-
dard procedure seems to adequately sample
the kidney.
Reference was made to renal accumula-
tion ofgabapentin and to its ability to bind
a2u-globulin. Metabolic disposition data
revealed no differences in the accumulation
of gabapentin in the kidney of male and
female rats. Gabapentin distributes rapidly
to the kidney in both sexes, and approxi-
mately 10-12% ofthe dose is found at 2-
hr post-dose. The elimination decay is
rapid, and 0.20-0.14 gabapentin radioe-
quivalents in micrograms per gram are
found at 12 hr post-dose. Full profile toxi-
cokinetic studies have shown linear kinet-
ics without accumulation, and elimination
follows rapid clearance from the plasma
and organ compartments. Recoveries in
the mass balance studies yielded 99% or
more ofthe administered dose.
Why such a diverse series of chemicals
causes a putatively similar microglobulin
nephropathy with (i.e., unleaded gasoline)
and without (i.e., gabapentin) nephrocar-
cinogenesis is intriguing.
Evaluation ofthe gabapentin data does
not prove or disprove that a2u-globulin
accumulation precedes, promotes, or caus-
es renal cancer in rats over a 2-year con-
stant exposure at toxicity-limiting doses.
We propose that although morphofunc-
tional features may appear similar for all
documented cases of this xenobiotic-
induced nephropathy, different mecha-
nisms may be operative. Alternatively, a
structural comparison of the x2u
microglobulin species would assert this
microglobulin not to be the same in all
cases when induced by the diverse chemi-
cals. The work by Hildebrand et al. (9)
would indicate some support to this
notion. In the case ofgabapentin, in which
we have substantial data on hand, it is dif-
ficult to advocate existing mechanisms
because ofthe drug's lack ofmetabolism or
biotransformation, lack of serum protein
binding, or lack of significant organ accu-
mulation. It remains unanswered whether
data on cell proliferation or specific 4x2u-
globulin binding to renal tubule proteins
would substantiate current mechanisms.
Clearly new data, rather than new assump-
tions, will give fresh insight to our under-
standing ofthe a2u nephropathy puzzle.
FelixA. de la Iglesia
Alexander W. Gough
Robert E. Sigler
Pathology and Experimental Toxicology
Parke-Davis Pharmaceutical Research
Division, Warner-Lambert Company
Ann Arbor, Michigan
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Weight of Evidence Versus
Weight of Speculation to
Evaluate the o2u-Globulin
Hypothesis
In response to a challenge fromJohn Ashby
(1) to identify chemicals that demonstrate
inconsistency with the a2u-globulin
nephropathy/rat kidney cancer hypothesis,
James Huff (2) described the responses of
seven relevant chemicals in an accompany-
ing correspondence. Evidently that response
hit a sensitive nerve in Daniel Dietrich (3),
resulting in his needless attackon those who
profess different views on this issue.
Dietrich claims that the a2u-globulin
mechanism has been "established and
meticulously proven" and chastises those
who "choose to ignore the obvious" by
questioning the validity of this "accepted
mechanism." To Dietrich, those who
doubt this hypothesis are guilty of "misin-
terpretation of available data." Would
Dietrich similarly criticize Short et al. (4),
including his own mentorJames Swenberg,
for acknowledging that "the exact mecha-
nism of cellular damage in cc2u [globulin]
nephropathy is unknown" or the EPA Risk
Assessment Forum (5) for concluding that
the at2u-globulin syndrome "should be
considered a satisfactory working hypothe-
sis but not a proven mechanism of action
to describe renal tubule cancer in male rats
exposed to CIGA" [chemicals that induce
tx2u-globulin accumulation]?
Rather amusing in this debate is that
Dietrich does exactly what he wrongfully
accuses Huff of doing, namely, misinter-
preting data and misrepresenting various
study findings to support his own view-
point. We chose to use only three of the
many distortions in Dietrich's letter for
illustration. First, Dietrich claims that
Partanen et al. (6) attributed the elevated
risk ofrenal cell cancer in humans exposed
to gasoline "to the tetraethyl-lead content
of the gasoline and not to the gasoline
(volatile hydrocarbons) itself." That is
wrong. Partanen et al. (6) actually wrote
that "our results suggest that some hydro-
carbon constituents) or additives) ofgaso-
line are conducive to renal cell cancer in
humans," and although "tetraethyl lead is
capable ofdermal entrance . .. the amount
of lead intake is probably low in the jobs
with typical dermal exposure to gasoline."
Furthermore, a recent epidemiological
study ofworkers exposed to gasoline vapors
(service station workers in the Nordic
countries) found a 30% excess risk of kid-
ney cancer with no excess risk ofleukemia
(7). The kidney cancer findings in humans
exposed to gasoline vapors correspond to
previously reported kidney cancer findings
in male rats, which Dietrich ironically dis-
misses as irrelevant to human risk because
ofa2u-globulin accumulation.
Second, Dietrich attempts to explain the
nonconcordance between lindane-induced
a2u-globulin nephropathy and the lack ofa
male rat kidney tumor response byspeculat-
ing about relationships among exposure to
lindane, testicular atrophy, serum testos-
terone levels, and a2u-nephropathy.
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Dietrich and Swenberg (8) reported that a
daily dose of 10 mg/kg lindane induces a
"marked increase in a2u-globulin" in the
kidney of male F344 rats. The National
Cancer Institute's carcinogenicity feed study
on lindane found no increase in kidney can-
cer or testicular atrophy in dosed rats com-
pared to controls (91S. Conversely, in a sepa-
rate review of that study, Reuber (10)
reported that the incidences of moderate
and severe testicular atrophy were increased
in the 472 ppm dose group (equivalent to
20 mg/kg/day) but not in the 236 ppm dose
group (equivalent to 10 mg/kg/day) and
that the incidence and severity of chronic
renal disease, but not kidney cancer, was
increased in both dose groups of male rats.
Thus, lindane did not induce kidney
tumors in male rats at a dose that caused a
marked increase in renal a2u-globulin accu-
mulation and that was not associated with
testicular atrophy. Furthermore, there are
no data available on the effects of lindane
on testosterone production in Leydig cells
or on dose-response relationships between
testicular atrophy in rats treated with lin-
dane, serum testosterone levels, and effects
on hepatic a2u-globulin synthesis. In spite
of this limitation, Dietrich did not hesitate
to conclude why this a2u-binding com-
pound did not induce kidney tumors:
"Based on the assumption that high levels of
a2u-globulin could not have been main-
tained in male rats treated with high doses
oflindane in the 2-year bioassay, due to tes-
ticular atrophy and thus a lack of testos-
terone, it becomes obvious why renal
tumors did not develop in lindane-treated
male rats." We believe that "obvious conclu-
sions" should be based on data rather than
assumptions. Indeed, alternative explana-
tions (e.g., a2u-globulin accumulation is
not predictive ofkidney tumor response) are
compatible with available data and should
be tested experimentally.
Third, Dietrich has misrepresented the
findings of Green et al. (11) on the influ-
ence of a2u-globulin accumulation in the
renal carcinogenicity of perchloroethylene
in male rats. In an inhalation study ofper-
chloroethylene by the National Toxicology
Program, renal tubular cell neoplasms were
induced in male rats exposed to 200 or 400
ppm (12). In their studies on the mecha-
nisms of tumor induction by perchloroeth-
ylene, Green et al. (11) reported that "this
response [accumulation of protein droplets
(c2u-globulin) in the P2 segment of the
kidney proximal tubules] was not seen after
inhalation exposure to 400 ppm per-
chloroethylene for 28 days and hence may
not be associated with the tumors seen at
this dose level." Rather than noting the
actual findings ofthis study, Dietrich chose
to exaggerate Green's inferences by claiming
that "the tumors observed in the male rat
kidney appear to be related to acombination
of at least two mechanisms: genotoxicity
from theP-lyase pathway and the a2u-glob-
ulin mechanism." This is a scientifically
unjustified conclusion.
Has the x2u-globulin hypothesis been
"meticulously proven" as claimed by
Dietrich? One attempt to develop a
dosimetry model based on the cx2u-globu-
lin hypothesis and which includes synthe-
sis, excretion, degradation, and renal accu-
mulation of x2u-globulin has been report-
ed (13). However, this model was not able
to simulate the renal accumulation ofa2u-
globulin in male rats dosed with 2,4,4-
trimethyl-2-pentanol, even when the renal
degradation rate ofthe a~2u-ligand complex
was assumed to be inhibited beyond what
has been reported in the literature [100%
inhibition rather than the 30% inhibition
reported by Lehman-McKeeman et al.
(14)]. Because this test ofthe a2u-globulin
hypothesis (the only one performed to
date) could not reproduce the critical quan-
titative relationships between exposure to
an a2u-binding ligand and ct2u-globulin
accumulation observed in the male rat kid-
ney, development ofalternative hypotheses
based on the same available information is
necessary. Interestingly, Dietrich over-
looked this important study by Borghoffet
al. (13) in citing data to support the a2u-
globulin hypothesis. We agree with the
views ofde la Iglesia et al. (15) that "clearly
new data, rather than new assumptions,
will give fresh insight to our understanding
ofthe a2u nephropathypuzzle."
Dietrich and others (16) take the posi-
tion ofdeclaring that conclusions byoriginal
investigators should be accepted as valid,
whereas alternative interpretations of the
same data by other scientists (17) are distor-
tions offact. Unfortunately, incorrect specu-
lations by original investigators are not rare.
When this possibility exists and the conse-
quences of misinterpretation can adversely
affect public health, then it is incumbent on
responsible scientists to present their per-
spectives. For those who care about public
health, this is good enough reason to ques-
tion the validity of "accepted" mechanisms.
Furthermore, scientific advancement is
based on the principle ofrigorous hypothesis
testing. To accept and promote unproven
hypotheses as fact is equivalent to elevating
hypotheses to the level ofactual data. This is
harmful for the advancement of science.
Contrary to the view ofAshby (18), we hold
firm that there can be no compromise on
this issue. One serious result of uncritical
acceptance ofhypotheses is that experiments
aimed at identifying mechanistic details may
not be performed. A consequence of this
practice is to denigrate toxicology as a scien-
tific discipline.
Ronald L. Melnick
Michael C. Kohn
James Huff
National Institute ofEnvironmental
Health Sciences
Research Triangle Park, North Carolina
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Now available:
Directory of Clinical Consultants in Tropical Medicine and Travelers' Health
The 1997 edition of the Clinical Consultants Directory has just been issued by the American
Society of Tropical Medicine and Hygiene.
The publication contains a list of physicians who offer clinical consultative service in tropical
medicine, medical parasitology, and travelers' health. Details on office hours and services
provided by physicians are included in the directory.
The directory is maintained and updated by the American Committee on Clinical Tropical
Medicine and Travelers' Health (ACCTMTH), a subgroup of ASTMH. The purpose of
ACCTMTH is to promote the clinical aspects of tropical medicine, medical parasitology, and
travelers' health.
To order a copy of the directory, send a self-addressed 9x12 envelope with $1.24 postage to:
ASTMH Clinical Directory
60 Revere Drive
Suite 500
Northbrook, IL 60062
USA
The directory can also be accessed through the ASTMH home page at
http://www.astmh.org
Founded in 1951, ASTMH currently boasts over 3,000 members from more than 70 countries. ASTMH is the principal
organization representing scientists, clinicians, and others with interests in the prevention and control oftropical diseases.
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